Invest Kerala | Medical Equipment

Healthcare 4.0 Technology Centre

Medical Devices Cluster

Sector: Lifesciences & Healthcare Location: Trivandrum

The Healthcare 4.0 Technology Center would focus on
developing research capabilities in Cancer, High-risk diseases, Nippah virus outbreak etc. and become a
leader in providing innovative virtual reality
healthcare content across the globe
Due to the high capital investments required to build such a center, it is proposed to be built under the
aegis of a private player in collaboration with
government
Healthcare 4.0 Technology Center will be housed at the Life Science Park at Trivandrum
Bio360, Kerala’s first Life Sciences Park, is Kerala’s first major step in the field of Life Sciences. It is a
Kerala State Industrial Development Corporation (KSIDC) initiative and will be a cluster of research
institutions, sci-tech academia and companies, working in the field of Biotechnology
These activities would primarily be focused on the Innovation and Incubation Centre with inputs from the Bio-process facility

Investment Avenues

The Healthcare 4.0 Technology Center would be a specialised initiative to further enhance the healthcare capabilities of the state by embedding Industry 4.0 emerging technologies such as Big Data Analytics, Artificial Intelligence and Virtual Reality

Key features and offerings of the Park

Considering Indian Government’s focus to promote the biotechnology
sector, the Bio 360 Park could prove to be a flagship Government-led
initiative to facilitate common infrastructure for newer companies
entering the segment

OVERVIEW

Government of Kerala is establishing a Life Sciences Park at Trivandrum with world class infrastructure facilities for life science based industries and R&D institutions. KSIDC has envisaged setting up of an innovation ecosystem through establishment of a Park that is dedicated to promote Life Sciences in the region of Kerala. The Park in Trivandrum will provide the first integrated approach to life science research to markets covering all segments such as agriculture, food and nutrition, human health, animal health, industrial biotechnology and medical technology. Phase I of the proposed Life Sciences Park is under development and is planning to offer facilities such as an Innovation cum Incubation Center, Research cum Learning Center, Animal Science facility, Bio-Process facility, a Medtech prototyping, design and validation center and toxicology services among others. The objective of Phase I is to encourage innovation and provide various support services to incubated companies within the Bio Park. The in rastructure facilities such as power, water and internal roads have been completed in Phase I and implementation of projects are at various stages. Some of the projects that are coming up in park are Institute of Advanced Virology, Medical Devices Park, Innovation cum Incubation Centre etc. A small Lab Animal facility is also planned in Phase I to take care of the need of CROs/Vaccine companies as part of new drug discoveries. The second phase of the Bio 360 Life sciences Park is envisaged as a critical extension of Phase I, whereby it is proposed to acquire and develop another 130 acres of land for industrial use by companies in various sectors of life sciences to setup and operate standalone commercial manufacturing or related facilities. While Phase I boasts of offers significant level of shared facilities and incubation space for smaller companies, Phase II will offer larger parcel of land for companies to setup large scale commercial activity with their own facilities. Additionally, Phase II companies c n also benefit from the shared infrastructure in Phase.

The park provides ultra-modern facilities such as a cGMP compliant bio process facilities for pilot scale
production and a pre-clinical toxicology laboratory for
functional and strategic requirements.
The park is poised to be focal point for convergence of research innovation skill development to further
advance the frontiers of science
An extent of 86 acres of land has already been
acquired and steps have been taken to take
possession of remaining parcels of land so as to
makeabout 125 acresof land in contiguous form.
KSIDC is keen in associating with major players in Life
Sciences sector to develop the Phase II on PPP mode. Co-developer can conceive any projects in Life
Sciencesdomain.
The cost of land can be treated as equity of KSIDC, while, Co-developer can create all basic industrial
infrastructure such as power, water and internal roads
including common facilities needed for Life
Sciences/Biotechventurs

Project Parameter

▪ First phase-75 acres. Under possession is 70 acres
▪ Second phase -160 (128.50) acres. Under possession is 86 acres
Landallotments
▪ 12.75 Acres (Allotted); 30 Acres (under processing)
Balance land allottable
▪ First phase -14.25 acres Second phase -86 acre

FirstPhase
▪ cGMP compliant bio-processing facility,
▪ Small Laboratory Animal facility
▪ Wet & Dry Laboratory space
▪ Incubation Centre
SecondPhase
▪ Power, Water, Internal roads

Polyskin Life Sciences (P) Ltd
▪ Research cum Learning Centre by Kerala Veterinary & Animal Sciences
University
▪ Institute of Advanced Virology (Phase 1)

First phase -INR 1000 Cr
▪ Second phase -INR1500 Cr

First phase –INR 1500 Cr
▪ Second phase –INR 2500 Cr

Market Landscape

Indian industry has been a driver for access and affordability in life sciences. Indian drugs are available at an affordable price as compared to
markets globally.
India is the primary supplier of essential medicines for numerous diseases, helping save millions of lives globally. India’s contribution extends to developed markets such as the US as well, where through its position in the generics market, the
industry is significantly reducing healthcarecost.
In addition, it also generates a significant number of jobs for India. Estimates indicate that around 2.5 million people are currently employed by the
industry (including some of the industries such as
chemists, stockists,etc).
India has also been able to build a strong position across various segments of the market. In pharmaceuticals, India is now the eighth largest country by value globally with one of the highest
growthrates.
It has also been able to build a strong position in key markets such as the US. In clinical trials, India continues to be one of the top 15 destinations
globally based on the number of trials conducted between 2003 and 2013.
The State’s rich bio-diversity comprising of abundant flora and fauna has always fostered a thriving R&D
culture, giving birth to many research institutions in agriculture, Ayurveda, medical sciences, bio-technology, fisheries, marine sciences and more.

InvestmentOpportunity

The Bio 360 Life Sciences Park would provide
developed plots for large and Integrated Bio-IT companies to set up their campuses and ready-to-use modular officers, wet and dry lab space for intermediate, smalland start-up companies.

The immense knowledge base concentrated in the R & D clusters near the Park as well as across Kerala will
greatly enhance the Park’s efficiency as a single source R&Dand knowledge centre for theindustry.
The Start-up firms, small scale enterprises, student and scientist entrepreneurs, and companies with
expansion plans will particularly benefit from the proposed IncubationCentre.
‘Plug-n-play’ manufacturing space is guaranteed for commercial scale operations at post–
incubationstage
The park is India’s first research focused park with an integrated approach covering all segments such as
medical technology, pharmaceuticals, healthcare,
biotechnology.

Medical Devices Cluster

The medical device industry is one of the biggest industries in healthcare, driven by innovation and new technologies. With 50% of the global population slated to be over 65 years in 2039, the medical devices industry in developed nations is undergoing a strategic change, with the focus of the industry shifting from diagnosis to prevention. With a large aging population and the increased incidence of lifestyle and chronic diseases, innovations that reduce or eliminate hospital stays will be critical: remote healthcare, wireless enablement, minimally-invasive. The last decade has seen an unprecedented development of state-of-the-art medical devices and has acted as a growth enabler of the healthcare industry.

India is largely an importer of medical devices, with domestic industry accounting for about 2% of the global industry which stands at USD 250 Bn, as per the estimates. Central Government through its Make in India initiative has approved setting up of four medical devices parks in India. The medical parks aimed at providing world-class treatment at affordable prices will be established in Andhra Pradesh, Telangana, Tamil Nadu andKerala.

OVERVIEW

National brands to its territory. Not only is the private healthcare system strong in Kerala, but also the public healthcare system is equally equipped to boost the State’s healthcare condition. Kerala is going to further strengthen its position in healthcare by setting up of Medical Devices clusters. Kerala is uniquely poised to play the global hub role as it has institutions doing world class research, a higher education sector with the potential to supply manpower, tertiary hospitals doing advanced clinical procedures and patients demanding cutting-edge clinical procedures because of exposure to advanced countries. Growing medical tourism sector, good climate and standard of living which can attract the best of world experts, good international connectivity and emerging industrial infrastructure like electronics hardware park, polymer park, and manufacturing support structures are other factors. Kerala is home to some of the key players of Medical Device / Equipment Manufacturers such as Terumo Penpol, IB S Medical Equipment, LIMAS Medical Devices,etc. The medical devices parks will provide the necessary infrastructure to the companies where they can easily come and install their setup. The parks will be a one-stop facility for manufacturing units through the creation of an integrated ecosystem to facilitate business, stimulate innovation and develop newtechnologies and become a hub for medical technology sector. The medical devices park will also incubate Startups based on medical technology. The park will pave way for manufacturing of high-end items like imaging equipment, pacemakers, etc. which are currently being imported and bring down the costs making healthcare more affordable to public.

Project Parameter

Area of around 250 – 300 Acres. Will contain the under-mentioned;

• Pre-Built ManufacturingUnits
• Common Scientific Facilities
• Common Commercial Facilities
• Strategic support for Ecosystem Development

The medical device cluster will generate direct and indirect
employment of around 15,000people
The consortium will invest around INR 200 crore in development and promotion of a greenfield Ernakulam
district. The manufacturing facility will be set up in an area of around 200 acres of land and is expected to get a good investment from constituent units that will be set up in the park. It will be a state-of-the-art manufacturing facility for the electronics medical industry. The park will provide the
necessary infrastructure to the companies where they can easily come and install their setup.

Market Landscape

India’s healthcare industry is one of the fastest growing sectors and it is expected to reach USD 280 billion by 2020. Indian medical devices industry is growing at a CAGR of 15.8%, vis-à-vis a CAGR of
4.1% for the Global medical devices industry.

India is the 4th largest market for medical devices in Asia, top 20 Globally.
Kerala has the highest per capita expenditure on health in the country during 2014, at INR 7,636. (India
average in INR 3,800). State’s average annual
expenditure on health is about INR 25,000crore.
Medical devices industry in India has the potential to grow at 28% p.a. to reach USD 50 billion by 2025.
Kerala Strong Infrastructure: 6,103 hospitals, 100,687 beds, 20,554 doctors and 33,382 nurses
Kerala has been synonymous with wellness & Ayurveda and has the potential to attract medical value travelers. It can generate USD1
billion by 2020 through MVT.

Investment Opportunity

Kerala will design and implement its schemes in the health sector in sync with the United Nations’ (U.N.)
Sustainable Development Goals (SDGs) so as to address all its core issues in health by 2030. Leading hospitals in
Kerala have formed a consortium to promote the State as a medical value travel destination worldwide.
The draft Kerala Health Policy is also aimed at revamping the health-care system in the State and is expected to be
launched in near future. The State is also planning to adopt antibiotic resistance policy. Government has created
Investor friendly policies for the private players to enhance the establishment of healthcare facility in various sectors.
Some of the potential Sectors include Biotech R & D Services, Bio-Informatics, Bio- Services, Bio-Medical
Technology, Bio-Pharma, Nutraceuticals etc.
Kerala offers a strong research base, in terms of trainable skilled human resource and educational infrastructure.
There are Finishing school to provide industry ready man power. 100% FDI allowed in medical devices through the
automatic route o

Kerala will design and implement its schemes in the health sector in sync with the United Nations’ (U.N.) Sustainable Development Goals (SDGs) so as to address all its core issues in health by 2030. Leading hospitals in Kerala have formed a consortium to promote the State as a medical value travel destination worldwide.

The draft Kerala Health Policy is also aimed at revamping the health-care system in the State and is expected to be launched in near future. The State is also planning to adopt antibiotic resistance policy. Government has created investor friendly policies for the private players to enhance the establishment of healthcare facility in various sectors. Some of the potential Sectors include Biotech R & D Services, Bio-Informatics, Bio- Services, Bio-Medical Technology, Bio-Pharma, Nutraceuticals etc.
Kerala offers a strong research base, in terms of trainable skilled human resource and educational infrastructure. There are Finishing school to provide industry ready man power. 100% FDI allowed in medical devices through the automatic route of Brownfield as well as Greenfield setups. There are various other tax and other incentives offered by the Government.

Sector: Lifesciences & Healthcare Location: Trivandrum

Impact On The Economy

OVERVIEW

Get to Know Us: Kerala's Investment Destination of Choice.

Medical Devices Cluster

Impact On The Economy

OVERVIEW

Get to Know Us: Kerala's Investment Destination of Choice.